-
Why some people don't lose weight with Wegovy
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21%... Read more -
Philly's soda tax had an impact on health in the city, research finds
When University of Pennsylvania researcher Christina Roberto set out to study Philadelphia's soda tax, she wasn't convinced she would find... Read more -
Team discovers that a key mechanism in fat cells protects the body against energetic excess
A research team has identified an essential mechanism in fat cells (adipocytes) that enables them to enlarge safely to store... Read more -
208 million Americans are classified as obese or overweight, according to new study on 132 data sources
Nearly half of adolescents and three-quarters of adults in the U.S. were classified as being clinically overweight or obese in... Read more -
The role of social media in the stigmatization of persons living with obesity
Through an analysis of posts on Twitter (now rebranded X) relating to obesity published between April 2019 and December 2022,... Read more -
Biden will move to have Medicare, Medicaid cover GLP-1 weight-loss meds
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered... Read more -
Popular diabetes and obesity drugs also protect kidneys, study shows
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have... Read more -
Study examines California's legislative efforts on obesity
A recent multi-campus study, co-led by public health researchers from UC Irvine and UC Merced, published in the journal BMC... Read more -
Taking a GLP-1 medication? Expert offers tips for holiday eating
So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but... Read more -
Metabolic and bariatric surgery safe and effective for patients with severe obesity
A team of researchers led by Pennington Biomedical Research Center's Dr. Florina Corpodean has confirmed through a data analysis that... Read more -
New study tracks leptin pulse patterns, a potential clue to understanding obesity
Obesity has become a global epidemic, and the need for treatment and monitoring for people with obesity is growing. Researchers... Read more -
Surprising patterns in infant growth after gestational diabetes exposure challenge current views on obesity risk
A new study led by researchers at The University of Texas at Austin and Harvard Medical School reveals surprising findings... Read more -
Clinical study supports the anti-obesity effects of kimchi
Approximately 16% of the global population, or about 890 million people, suffer from obesity. The World Health Organization (WHO) has... Read more -
Basic rules for screen time at a young age can help reduce childhood obesity—new research
Childhood obesity is a growing concern worldwide. But in New Zealand it's a particularly pressing issue.... Read more -
More than half of U.S. adults could be candidates for Ozempic
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide,... Read more
